MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/iid3.70368

Медицинская библиотека · Immunity, inflammation and disease · 2026

Early Mortality Following Systemic Anticancer Therapy in Lung Cancer: A Bayesian Spatiotemporal Multilevel Analysis.

Tesema Getayeneh Antehunegn, Stirling Rob G, Wah Win, Tessema Zemenu Tadesse, Heritier Stephane, Earnest Arul

СтатьяПеревод пока не подготовлен

Аннотация

INTRODUCTION

Despite advances in lung cancer treatment, early mortality following Systemic Anticancer Therapy (SACT) remains a major concern. Identifying patients at high risk of early mortality may inform treatment decision-making, particularly where SACT may offer limited benefit. We aimed to quantify spatiotemporal patterns of early mortality following SACT and to examine the relative contributions of individual- and area-level risk factors.

METHODS

We conducted a secondary analysis of data from the Victorian Lung Cancer Registry. Bayesian spatiotemporal multilevel models were used to assess associations between individual- and area-level factors and early mortality following SACT. Adjusted Odds Ratios (AORs) with 95% Credible Interval (Crl) were reported to indicate statistical significance.

RESULTS

Substantial spatiotemporal variation in early mortality following SACT was observed across Victoria. Factors associated with increased odds of early mortality included age ≥ 60 years (AOR = 1.06, 95% Crl: 1.01-1.22), clinical stage II (AOR = 1.15, 95% Crl: 1.01-1.59), stage III (AOR = 1.28, 95% Crl: 1.01-2.05), stage IV (AOR = 3.19, 95% Crl: 2.12-5.07), comorbidity (AOR = 1.12, 95% Crl: 1.01-1.34), and poor performance status (AOR = 3.09, 95% Crl: 2.24-4.24). Presentation at a multidisciplinary meeting (AOR = 0.66, 95% Crl: 0.52-0.88) and receipt of supportive care screening (AOR = 0.53, 95% Crl: 0.41-0.69) were associated with reduced odds of early mortality.

CONCLUSION

Marked spatiotemporal variation in early mortality following SACT highlights the need for targeted, risk-informed treatment strategies, particularly for patients with advanced disease, comorbidities, poor performance status, and those residing in high-risk areas.

Для цитирования: Tesema Getayeneh Antehunegn, Stirling Rob G, Wah Win, Tessema Zemenu Tadesse, Heritier Stephane, Earnest Arul. Early Mortality Following Systemic Anticancer Therapy in Lung Cancer: A Bayesian Spatiotemporal Multilevel Analysis.. Immunity, inflammation and disease. 2026. DOI: 10.1002/iid3.70368.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.